Medicine and Dentistry
Breast Cancer
100%
Pathologist
90%
Diagnosis
80%
Neoplasm
69%
Low and Middle Income Countries
54%
Malignant Neoplasm
47%
Cross Sectional Study
40%
Cytotechnology
38%
Prevalence
35%
Biopsy Technique
32%
Metastatic Breast Cancer
27%
Human Immunodeficiency Virus
25%
Fine-Needle Aspiration
25%
Diseases
24%
Child Health
24%
COVID-19
23%
Social Determinants of Health
23%
Burkitt's Lymphoma
21%
Laboratory Medicine
21%
Breast Examination
20%
Helicobacter Pylori
20%
Cohort Analysis
20%
Patient Referral
20%
Ferritin
19%
Stillbirth
18%
4 Iodo 2,5 Dimethoxyamphetamine
18%
Breast Cancer Screening
18%
Lymphatic System Tumor
18%
Breast Cancer Molecular Subtype
18%
Cancer Diagnosis
18%
Helicobacter Infection
18%
Anemia
17%
Odds Ratio
17%
Comorbidity
17%
Metastatic Carcinoma
17%
Cohort Effect
16%
Disease
16%
Estrogen Receptor
16%
Diffuse Large B-Cell Lymphoma
15%
Radiation Therapy
15%
Infection
15%
Epstein Barr Virus
14%
Awareness
14%
Neonatal Infant
13%
Fetus Growth
13%
Prenatal Care
13%
Cancer Staging
12%
Lung
12%
Informed Consent
12%
Receptor
12%
Progesterone Receptor
11%
Pre-Eclampsia
11%
Translational Research
11%
Telepathology
11%
Laboratory Test
11%
Aspiration Cytology
11%
Cytodiagnosis
11%
Triple Negative Breast Cancer
11%
Cancer Risk Factor
10%
Infectious Disease
10%
Meta-Analysis
10%
Diagnostic Accuracy
10%
Prognostic Factor
10%
microRNA
10%
Maternal Welfare
10%
Vitamin D
10%
Cancer
10%
Medicine
9%
Leukemia
9%
Patient Care
9%
Toddlers
9%
Childhood Mortality
9%
Neonates
9%
Dermatosis
9%
Staphylococcus Aureus
9%
Urban Population
9%
Metabolic Syndrome
9%
P16
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Recurrent Disease
9%
Serotype
9%
Immunoglobulin G Antibody
9%
Seroprevalence
9%
Oncology
9%
Bone Marrow Biopsy
9%
Kaposi Sarcoma
9%
Protein P53
9%
Cytopathology
9%
Nodular Lymphocyte Predominant Hodgkin's Lymphoma
9%
Embryonal Rhabdomyosarcoma
9%
Curettage
9%
Carcinoid
9%
Anatomical Pathology
9%
Population Research
9%
Uterine Inversion
9%
Endocrine Disease
9%
Diagnostic Pathology
9%
Low Drug Dose
9%
Breast Density
9%
Sentinel Lymph Node Biopsy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
34%
Cross-Sectional Study
22%
Combination Therapy
20%
Breast Cancer
18%
Ferritin
18%
Clinical Trial
18%
Malaria Falciparum
18%
Diseases
14%
Artemisinin
14%
Infection
13%
Artemether Plus Benflumetol
11%
Comorbidity
10%
Neoplasm
10%
Antimalarial Agent
10%
Primaquine
9%
Helicobacter Pylori
9%
Sepsis
9%
Antimicrobial Resistance
9%
Ceftriaxone
9%
Methicillin-Resistant Staphylococcus Aureus
9%
Biological Marker
9%
SARS Coronavirus
9%
Ovary Carcinoma
9%
Vitamin D
9%
Extrapulmonary Tuberculosis
9%
Salmonella Enterica Serovar Typhimurium
9%
D Dimer
9%
Breast Cancer Molecular Subtype
9%
Immunoglobulin G Antibody
9%
Systemic Treatment
9%
Formaldehyde
9%
Acute Toxicity
9%
Receptor
9%
Phase II Trials
9%
Protein P53
9%
Cohort Study
9%
Dexamethasone
9%
Seroprevalence
9%
Cytokine Storm
9%
Matrix-Assisted Laser Desorption/Ionization
9%
Piperaquine
9%
Blood Lead Level
9%
Premature Labor
9%
Molecular Marker
9%
Anemia
9%
Salmonella
7%
Estrogen Receptor
7%
Progesterone Receptor
7%
Staphylococcus Aureus
6%
Lead-Acid Battery
6%
Vitamin D Deficiency
6%
Hypovitaminosis D
6%
Stillbirth
6%
Gram Negative Bacterium
5%
Parathyroid Hormone
5%
Immunology and Microbiology
Prevalence
35%
Helicobacter Pylori
27%
Methicillin-Resistant Staphylococcus Aureus
18%
Antibiotic Sensitivity
16%
Antimicrobial Resistance
15%
Staphylococcus Aureus
14%
Plasmid
11%
Gene Expression
11%
B Cell
10%
Normal Human
9%
Salmonella
9%
Seroprevalence
9%
Population Structure
9%
Immunity
9%
Cytomegalovirus
9%
Tumor-Associated Macrophage
9%
Entamoeba Histolytica
9%
Serotype
9%
Rubella
9%
Oncogene C Myc
9%
Toxoplasma gondii
9%
Salmonella Enterica Serovar Typhimurium
9%
Hepatitis A
9%
Parasite Prevalence
9%
Time-of-Flight Mass Spectrometry
9%
Matrix-Assisted Laser Desorption-Ionization
9%
Epstein Barr Virus
9%
Ferritin
9%
Mucosa
9%
Streptococcus Agalactiae
9%
Immune System Receptors
9%
Streptococcus Pneumonia
9%
Hemoglobin
9%
Patient Coding
9%
Antimalarial Drug Resistance
9%
Host
8%
Real Time Polymerase Chain Reaction
6%
Bovine
6%
Gram-Negative Bacteria
5%
Plasmacytoma
5%
Real-Time Polymerase Chain Reaction
5%
Virus Latency
5%
Tumor-Infiltrating Lymphocytes
5%